China SXT Pharmaceuticals, Inc. (SXTC)

This company does not disclose its interest income, and we cannot confirm it is within the AAOIFI limit.

AAOIFI Standard 21 allows income from prohibited sources such as interest of up to 5% of a company's total income. China SXT Pharmaceuticals, Inc. does not report its interest income as a separate line in its financial statements. For most companies we can still settle this test from the size of their cash and investments, but China SXT Pharmaceuticals, Inc. holds enough relative to its revenue that the figure could fall on either side of the limit. Rather than guess, we hold the verdict under review and re-check every filing.